LONDON BROKER RATINGS: Morgan Stanley cuts Mondi; BofA cuts Ashtead
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More
| Price | 494.50p on 05-02-2026 at 19:40:05 |
|---|---|
| Change | -1.00p -0.2% |
| Buy | 499.00p |
| Sell | 496.00p |
| Last Trade: | Unknown 1,097.00 at 498.50p |
| Day's Volume: | 966,307 |
| Last Close: | 494.50p |
| Open: | 493.00p |
| ISIN: | GB00B45C9X44 |
| Day's Range | 490.50p - 505.00p |
| 52wk Range: | 297.50p - 614.00p |
| Market Capitalisation: | £1.33b |
| VWAP: | 496.5194p |
| Shares in Issue: | 268.97m |
Chemring (CHG) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 1,097 | 498.50p | OTC Trade |
16:29:45 - 05-Feb-26 |
| Unknown* | 0 | 498.50p | SI Trade |
16:29:10 - 05-Feb-26 |
| Sell* | 20 | 498.50p | Automatic Execution |
16:29:10 - 05-Feb-26 |
| Sell* | 304 | 498.50p | Automatic Execution |
16:28:55 - 05-Feb-26 |
| Sell* | 22 | 498.50p | Automatic Execution |
16:28:55 - 05-Feb-26 |
| Sell* | 293 | 498.50p | Automatic Execution |
16:28:25 - 05-Feb-26 |
| Sell* | 22 | 498.50p | Automatic Execution |
16:28:25 - 05-Feb-26 |
| Sell* | 200 | 498.50p | Automatic Execution |
16:28:21 - 05-Feb-26 |
| Sell* | 22 | 498.50p | Automatic Execution |
16:28:21 - 05-Feb-26 |
| Sell* | 288 | 498.50p | Automatic Execution |
16:28:09 - 05-Feb-26 |
Chemring (CHG) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 2nd Feb 2026 7:00 am | RNS | Total Voting Rights |
| 23rd Jan 2026 4:41 pm | RNS | Director/PDMR Shareholding |
| 12th Jan 2026 1:35 pm | RNS | Notice of AGM |
| 2nd Jan 2026 10:29 am | RNS | Total Voting Rights |
| 19th Dec 2025 11:53 am | RNS | Holding(s) in Company |
| 19th Dec 2025 11:53 am | RNS | Holding(s) in Company |
| 18th Dec 2025 7:00 am | RNS | Block listing Interim Review |
| 16th Dec 2025 7:00 am | RNS | Director/PDMR Shareholding |
| 16th Dec 2025 7:00 am | RNS | Director/PDMR Shareholding |
| 16th Dec 2025 7:00 am | RNS | Director/PDMR Shareholding |